Accelerating Synthetic & Phytocannabinoid Research & Development into Clinical Approvals for Neurological Obesity, Pain, Inflammatory Indications & More
Your Definitive Forum for Navigating the Clinical Pathway of Cannabinoid Therapies
Realizing the Potential of Endocannabinoid-System-Targeted & Cannabinoid Therapies
Struggling to navigate complex scientific, regulatory, and commercial challenges to bring safe, effective cannabinoid-based medicines to patients in need?
The 8th Cannabinoid & Endocannabinoid Drug Development Summit uniquely brings together 60+ leading experts from preclinical research, clinical trials, pharmacology, regulatory affairs, and intellectual property- offering a comprehensive, multidisciplinary platform.
Covering diverse therapeutic areas, from neurology and inflammation to endometriosis, join to engage in critical discussions, forge strategic partnerships, and gain the knowledge needed to overcome key hurdles in clinical development.
Now is the time to connect, collaborate, and drive forward the next generation of clinically validated cannabinoid therapies with pioneering experts from Ananda, Synendos, Indication BioSciences, Nalu Bio and more.
World-Class Speaker Faculty Includes:
Previously Attending Companies Include:
Our Partners:
Other Events In The Series:
